Vivos Therapeutics, Inc. (NASDAQ:VVOS) Short Interest Update

Vivos Therapeutics, Inc. (NASDAQ:VVOS) was the target of a significant decline in short interest in March. As of March 15th, there was short interest totalling 249,000 shares, a decline of 27.6% from the February 28th total of 344,000 shares. Currently, 5.4% of the shares of the company are sold short. Based on an average trading volume of 210,600 shares, the short-interest ratio is presently 1.2 days.

Hedge Funds Weigh In On Vivos Therapeutics

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Commonwealth Equity Services LLC lifted its holdings in shares of Vivos Therapeutics by 23.8% in the 4th quarter. Commonwealth Equity Services LLC now owns 26,000 shares of the company’s stock valued at $112,000 after buying an additional 5,000 shares during the period. Cutter & CO Brokerage Inc. purchased a new position in Vivos Therapeutics in the fourth quarter worth $163,000. Geode Capital Management LLC raised its position in Vivos Therapeutics by 55.6% in the fourth quarter. Geode Capital Management LLC now owns 44,827 shares of the company’s stock worth $192,000 after acquiring an additional 16,025 shares in the last quarter. Finally, Anson Funds Management LP acquired a new stake in Vivos Therapeutics in the fourth quarter valued at $1,041,000. Institutional investors and hedge funds own 26.35% of the company’s stock.

Vivos Therapeutics Stock Down 2.5 %

NASDAQ VVOS opened at $3.11 on Friday. The stock has a market capitalization of $18.32 million, a P/E ratio of -0.55 and a beta of 7.47. Vivos Therapeutics has a 52-week low of $1.91 and a 52-week high of $6.28. The firm has a 50-day moving average price of $3.78 and a 200 day moving average price of $3.60.

Vivos Therapeutics Company Profile

Vivos Therapeutics, Inc, a medical technology company, develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.